Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease

Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Journal of Clinical and Experimental Neuropsychology (Impact Factor: 2.08). 02/2010; 32(7):775-9. DOI: 10.1080/13803390903521018
Source: PubMed


While little is known about risk factors for cognitive impairment in early onset Parkinson disease (EOPD), postmortem studies have shown an association between dementia with Lewy bodies (DLB) and glucocerebrosidase (GBA) mutation. We compared Mini-Mental State Examination (MMSE) performance and self-reported cognitive impairment in 699 EOPD participants genotyped for mutations in parkin (PRKN), leucine-rich repeat kinase-2 (LRRK2), and GBA. Logistic regression was used to assess the association between reported cognitive impairment and MMSE score, as well as between GBA group membership and self-reported impairment and MMSE. GBA carriers reported more impairment, but MMSE performance did not differ among genetic groups. Detailed neuropsychological testing is required to explore the association between cognitive impairment and GBA mutations.

Download full-text


Available from: Susan Mickel
  • Source
    • "We posit that the significantly better performance of the GD only group is because of a sensory mechanism rather than because of better cognitive function than that of the other groups. Bearing in mind that in addition to visual acuity (which was not impaired in any of the participants), color discrimination may be influenced by cognitive function which in patients with GD+PD may be among the first and most notable functions to be affected [19] [23] [26], it is instructive that GD only patients performed better than the GBA carriers without PD, and that both the sub-groups of GD+PD and GBA carriers+PD performed better than the PD only group on virtually all outcome measures. Thus, these comparisons putatively control to some extent for the possible confounding effects of cognitive function both intra-and inter-group, by comparing persons with GD with each other and carriers of GBA mutations with each other. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Poor color discrimination among patients with Parkinson disease (PD) has long been recognized. It has been shown that carrying one or two mutations in the β-glucocerebrosidase gene (GBA) for the autosomal disease Gaucher disease (GD), as based initially on clinical evidence, is a genetic risk factor for early-onset PD. Objective: The purpose of this study was to assess color discrimination in patients with one or two GBA mutations relative to healthy controls to ascertain whether this function is affected when persons with GD or even one GBA mutation develop PD. Methods: The Farnsworth-Munsell 100 hue test (FMHT) was evaluated among patients with GD+PD compared to patients with GD only, obligate GBA carriers with and without PD, patients with PD only, and healthy controls. FMHT outcome include computer-generated TES (Total Error Score) and values recommended by Vingrys & King-Smith. Results: Six groups of 10 persons were tested. Significant differences were seen for male GD+PD and for age in PD. The highest mean TES was in the PD only group, the lowest in the GD only group. There was a significant difference because of PD in groups with GD and GBA carriers. GD+PD means were between GD only and PD only mean scores. Conclusions: These findings confirm that PD impacts color discrimination, more in males with GD+PD but nonetheless, GD+PD patients (but not GBA carriers) had better scores than PD only patients.
    Full-text · Article · Sep 2015 · Journal of Parkinson's Disease
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents experimental studies of a carbon-fiber emitter-array Using commercial carbon-fiber products, we built a carbon-fiber emitter-array gun. The gun consists of two accelerating stages to produce a long-pulse electron-beam array. It demonstrated ~400 μs pulses of ~0.1 A in each channel with this configuration. The gun was used in the carbon-fiber CRM-array experiment successfully
    No preview · Conference Paper · Feb 2000
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cognitive profile of early onset Parkinson's disease (EOPD) has not been clearly defined. Mutations in the parkin gene are the most common genetic risk factor for EOPD and may offer information about the neuropsychological pattern of performance in both symptomatic and asymptomatic mutation carriers. EOPD probands and their first-degree relatives who did not have Parkinson's disease (PD) were genotyped for mutations in the parkin gene and administered a comprehensive neuropsychological battery. Performance was compared between EOPD probands with (N = 43) and without (N = 52) parkin mutations. The same neuropsychological battery was administered to 217 first-degree relatives to assess neuropsychological function in individuals who carry parkin mutations but do not have PD. No significant differences in neuropsychological test performance were found between parkin carrier and noncarrier probands. Performance also did not differ between EOPD noncarriers and carrier subgroups (i.e., heterozygotes, compound heterozygotes/homozygotes). Similarly, no differences were found among unaffected family members across genotypes. Mean neuropsychological test performance was within normal range in all probands and relatives. Carriers of parkin mutations, whether or not they have PD, do not perform differently on neuropsychological measures as compared to noncarriers. The cognitive functioning of parkin carriers over time warrants further study.
    Full-text · Article · Jan 2011 · Journal of the International Neuropsychological Society
Show more